The question behind is it worth it
Nobody types this into a search bar because they want a pharmacology lecture. They type it because the monthly cost is real, they have been disappointed before, and they want to know whether this one is different. So here is the short answer first: for people who meet the clinical criteria, the evidence is stronger than for anything else available without surgery. Whether that makes it worth it for you depends on three things the marketing rarely mentions.
The first is that it is a monthly cost, not a one-off. The second is that some of what you lose is muscle unless you do something about it. The third is that appetite comes back when you stop. None of those makes the treatment a bad idea. All three change the maths.
What you are actually paying for each month
There are two separate bills and keeping them apart is the single most useful thing you can do when comparing providers. One is the program cost, which covers the assessment, the prescribing decision and the reviews. The other is the medication, which a pharmacy bills at its own price.
A monthly figure that does not say which of those it covers is not a price. Ask for both in writing before you commit to anything, because the gap between two providers is usually in what the programme fee includes rather than in the drug.
- The programme fee: assessment, prescribing, and how many reviews are included
- The medication: billed by the pharmacy, and it rises as the dose steps up
- Anything else: bloodwork, a shipping charge, a cancellation term
Medication figures move by product, by pharmacy and by dose, so any number you read online is an example range rather than a quote. Fees vary by case, and the only figure that means anything is the one written down for you after an assessment. That is also why insurance coverage is worth checking before you start rather than after.
What the trial evidence actually says
Average weight loss in the trials was around fifteen percent of body weight on semaglutide and around twenty percent on tirzepatide, measured over roughly sixty-eight weeks. Those are averages across large groups over more than a year, not a prediction for any individual, and the spread around them is wide.
What that means in practice is that the shape of the curve is predictable even though your number is not. Month one is slow because the dose is still a settling dose. Months three to six are usually the steepest stretch. After that it flattens, and a realistic weight loss timeline matters more than any single figure.
Anyone quoting you a personal number before an assessment is guessing.
Whether you qualify at all
The usual threshold is a BMI of 30 and above, or 27 and above with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea. The BMI requirements are the starting point rather than the whole test.
Your history matters as much as the number. Certain thyroid cancer histories, pancreatitis, pregnancy and a few other situations rule treatment out, and what else you take can change the plan considerably. A serious provider goes through all of it before prescribing, and tells some people no.
That last part is worth weighing when you compare providers. A service that finds everyone eligible is not assessing anyone.
The first month, told honestly
Almost everyone gets some digestive side effect, and almost all of it arrives in the days after starting or after a dose increase. Nausea leads the list, followed by feeling full very quickly, constipation and reflux. For most people it eases within one to two weeks.
Managing it is mostly about how you eat rather than what you take: smaller portions more often, protein first, and less fat at once. The other half is being willing to hold a dose rather than push through it. Most miserable first months are the result of going up too fast.
- Expect the days after each dose step to be the worst of it
- Change portion size before nausea forces you to
- Report anything that is not settling instead of enduring it
- Know the red flags: severe abdominal pain, or being unable to keep fluids down
The common side effects are manageable. The short list of serious ones is worth reading once before you start so you can tell the difference at eleven at night.
The part about muscle nobody advertises
Some of what comes off is lean tissue. That is true of every method of losing weight, and it matters more here because the drop in intake is larger and faster than dieting usually produces.
It is also the most fixable of the trade-offs. Getting enough protein at every meal and doing two resistance sessions a week limits it substantially. Neither requires a gym membership, and both matter more than any cardio you might add.
Skipping this is what leaves people lighter, weaker and with a lower resting metabolic rate than they started with, which then makes the weight harder to hold afterwards.
What happens when you stop
Appetite returns. The medication holds a fullness signal steady and that effect ends when the medication clears. Trial data shows most people regaining a substantial share of what they lost, and that is the single most important thing to understand before starting.
It is not an argument against treating. It is an argument for treating it as long-term care, the way blood pressure is treated, and for building the eating and training habits while the medication is still helping rather than afterwards. Planning how stopping medication would work is a fair question to ask at the first appointment.
So is it worth it, or not
For someone who meets the criteria, has tried the obvious things, and can carry the monthly cost for long enough to matter, the honest answer is usually yes. For someone below the thresholds, or looking for a short course to drop a stone before an event, it is the wrong tool and a good clinician will say so.
The way to find out which you are is an assessment rather than an article. Ours is free, it takes a few minutes, and it ends with a straight answer either way. Start with do I qualify, or read more about how weight loss treatment works first.